Risk of tuberculosis with anti‐tumor necrosis factor‐α therapy: substantially higher number of patients at risk in A sia-Reference-Cited by-同舟云学术

Risk of tuberculosis with anti‐tumor necrosis factor‐α therapy: substantially higher number of patients at risk in A sia

Published:2013-10-16 Issue:3 Volume:17 Page:291-298
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J Rheum Dis

Author:

Navarra Sandra V.¹,Tang Boxiong²,Lu Liangjing³,Lin Hsiao‐Yi⁴,Mok Chi Chiu⁵,Asavatanabodee Paijit⁶,Suwannalai Parawee⁷,Hussein Heselynn⁸,Rahman Mahboob U.⁹¹⁰

Affiliation:

1. Rheumatology Section University of Santo Tomas Manila Philippines

2. Outcomes Research Emerging Markets Pfizer Inc New York USA

3. Shanghai Institute of Rheumatology Renji Hospital Jiao Tong University School of Medicine Shanghai China

4. Department of Medicine Veterans General Hospital National Yang‐Ming University Taipei Taiwan

5. Department of Medicine Tuen Mun Hospital Hong Kong China

6. Rheumatology Unit Department of Medicine Phramongkutklao Hospital and College of MedicineBangkok Thailand

7. Internal Medicine Department Ramathibodi Hospital Mahidol University Bangkok Thailand

8. Department of Medicine Putrajaya Hospital Putrajaya Malaysia

9. Rheumatology Department Perelman School of Medicine at the University of Pennsylvania Philadelphia PennsylvaniaUSA

10. Inflammation Medical Affairs Emerging Markets Pfizer Inc New York USA

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1756-185X.12188

Reference39 articles.

1. TNF alpha Inhibition as Treatment Modality for Certain Rheumatologic and Gastrointestinal Diseases

2. Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls

3. Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden

4. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti–tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register

5. Infections and anti-tumor necrosis factor ? therapy

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mycobacterial Infections;Rook's Textbook of Dermatology;2024-03-19

2. Ocular toxoplasmosis following anti-tumour necrosis factor-α therapy combined with oral methotrexate therapy: A case report and review of literature;European Journal of Ophthalmology;2023-10-11

3. Therapeutic Utility and Adverse Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs in Inflammatory Arthritis;International Journal of Molecular Sciences;2022-11-11

4. A case of paradoxical response during anti-tuberculosis treatment in a patient with ulcerative colitis;Clinical Journal of Gastroenterology;2022-03-04

5. Personalized medicine in India: Mirage or a viable goal?;Indian Journal of Rheumatology;2022